Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

NCT02569879 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02569879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02569879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 1, 2015
Completion date
April 14, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, aspergillosis, allergic bronchopulmonary, diphtheria, diphtheria-tetanus-acellular pertussis vaccines, tetanus